Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Buckeye Partners, L.P. (BPL): Two Important Indicators To Keep An Eye On

Buckeye Partners, L.P. (NYSE:BPL) has seen a decrease in activity from the world’s largest hedge funds in recent months; in our experience, stagnant interest is a slightly negative development.

To the average investor, there are plenty of gauges shareholders can use to monitor stocks. A pair of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best money managers can outclass the market by a healthy margin (see just how much).

Buckeye Partners, L.P. (NYSE:BPL)

Just as beneficial, bullish insider trading sentiment is a second way to parse down the stock market universe. Obviously, there are plenty of reasons for a bullish insider to sell shares of his or her company, but just one, very obvious reason why they would behave bullishly. Various academic studies have demonstrated the valuable potential of this method if piggybackers know what to do (learn more here).

Consequently, we’re going to take a peek at the recent action regarding Buckeye Partners, L.P. (NYSE:BPL).

How are hedge funds trading Buckeye Partners, L.P. (NYSE:BPL)?

At the end of the fourth quarter, a total of 6 of the hedge funds we track held long positions in this stock, a change of 0% from the third quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were increasing their holdings meaningfully.

Of the funds we track, First Eagle Investment Management, managed by Jean-Marie Eveillard, holds the most valuable position in Buckeye Partners, L.P. (NYSE:BPL). First Eagle Investment Management has a $13.4 million position in the stock, comprising less than 0.1%% of its 13F portfolio. On First Eagle Investment Management’s heels is Michael Messner of Seminole Capital (Investment Mgmt), with a $10.8 million position; the fund has 0.6% of its 13F portfolio invested in the stock. Other hedgies with similar optimism include Jim Simons’s Renaissance Technologies, Ken Griffin’s Citadel Investment Group and Phil Frohlich’s Prescott Group Capital Management.

What have insiders been doing with Buckeye Partners, L.P. (NYSE:BPL)?

Bullish insider trading is most useful when the primary stock in question has seen transactions within the past six months. Over the latest half-year time frame, Buckeye Partners, L.P. (NYSE:BPL) has seen zero unique insiders buying, and 1 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Buckeye Partners, L.P. (NYSE:BPL). These stocks are Targa Resources Partners LP (NYSE:NGLS), Cheniere Energy Partners LP (NYSEAMEX:CQP), Sunoco Logistics Partners L.P. (NYSE:SXL), Boardwalk Pipeline Partners, LP (NYSE:BWP), and Western Gas Partners, LP (NYSE:WES). All of these stocks are in the oil & gas pipelines industry and their market caps match BPL’s market cap.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.